Literature DB >> 17111167

[The value of the modified Gleason grading system of prostate adenocarcinoma in routine urological diagnostics].

B Helpap1, L Egevad.   

Abstract

In several consensus conferences of the International Society of Urological Pathology (ISUP), the Gleason grading system of prostatic carcinomas was modified and adapted to the routine histological diagnostics of specimens of core needle biopsies and radical prostatectomies. The main results are the documentation of all histological patterns (primary, secondary, tertiary) and a shifting of the maximal Gleason score of biopsies from 6 to 7a (3+4) and of radical prostatectomies from 6 and 7 to 7a and 7b (4+3). Score 2 to 4 carcinomas do not exist in the peripheral prostate. pT2 prostatic carcinomas with good prognosis have a maximal score of 7a; pT3 carcinomas with poor prognosis have a most frequent score of 7b. The agreement of the Gleason scores of core needle biopsies and radical prostatectomy specimens is more than 80%. Inter- and intraobserver reproducibility is better than after the conventional Gleason grading. The prognostic value of scores 6 and 7a may be similar. The border between low- and high-grade prostatic carcinoma may be probably Gleason score 7a and 7b. The prognostic value of score 6 should be changed to score 7a in the different therapeutic options for prostatic carcinomas.

Entities:  

Mesh:

Year:  2007        PMID: 17111167     DOI: 10.1007/s00120-006-1238-9

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  12 in total

1.  The prognostic significance of tertiary Gleason patterns of higher grade in radical prostatectomy specimens: a proposal to modify the Gleason grading system.

Authors:  C C Pan; S R Potter; A W Partin; J I Epstein
Journal:  Am J Surg Pathol       Date:  2000-04       Impact factor: 6.394

Review 2.  Current practice of Gleason grading of prostate carcinoma.

Authors:  Antonio Lopez-Beltran; Gregor Mikuz; Rafael J Luque; Roberta Mazzucchelli; Rodolfo Montironi
Journal:  Virchows Arch       Date:  2005-11-23       Impact factor: 4.064

Review 3.  The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma.

Authors:  Jonathan I Epstein; William C Allsbrook; Mahul B Amin; Lars L Egevad
Journal:  Am J Surg Pathol       Date:  2005-09       Impact factor: 6.394

4.  The significance of modified Gleason grading of prostatic carcinoma in biopsy and radical prostatectomy specimens.

Authors:  Burkhard Helpap; Lars Egevad
Journal:  Virchows Arch       Date:  2006-11-08       Impact factor: 4.064

5.  A UK-based investigation of inter- and intra-observer reproducibility of Gleason grading of prostatic biopsies.

Authors:  J Melia; R Moseley; R Y Ball; D F R Griffiths; K Grigor; P Harnden; M Jarmulowicz; L J McWilliam; R Montironi; M Waller; S Moss; M C Parkinson
Journal:  Histopathology       Date:  2006-05       Impact factor: 5.087

6.  Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update.

Authors:  A W Partin; M W Kattan; E N Subong; P C Walsh; K J Wojno; J E Oesterling; P T Scardino; J D Pearson
Journal:  JAMA       Date:  1997-05-14       Impact factor: 56.272

7.  Classification of prostatic carcinomas.

Authors:  D F Gleason
Journal:  Cancer Chemother Rep       Date:  1966-03

Review 8.  Gleason grading and prognostic factors in carcinoma of the prostate.

Authors:  Peter A Humphrey
Journal:  Mod Pathol       Date:  2004-03       Impact factor: 7.842

9.  Interobserver reproducibility of percent Gleason grade 4/5 in total prostatectomy specimens.

Authors:  Axel Glaessgen; Hans Hamberg; Carl-Gustaf Pihl; Birgitta Sundelin; Bo Nilsson; Lars Egevad
Journal:  J Urol       Date:  2002-11       Impact factor: 7.450

Review 10.  Fundamentals on the pathology of prostatic carcinoma after brachytherapy.

Authors:  Burkhard Helpap
Journal:  World J Urol       Date:  2002-08-15       Impact factor: 4.226

View more
  5 in total

Review 1.  [Prostate gland - what would urologists like to know from radiologists?]

Authors:  U B Liehr; D Baumunk; S Blaschke; F Fischbach; B Friebe; F König; A Lemke; P Mittelstädt; M Pech; M Porsch; J Ricke; D Schindele; S Siedentopf; J J Wendler; M Schostak
Journal:  Radiologe       Date:  2017-08       Impact factor: 0.635

2.  [Patients with prostate cancer after radical prostatectomy: Stage migration and changes in tumor characteristics from 1998-2012].

Authors:  A Walther; M Kron; T Klorek; J E Gschwend; K Herkommer
Journal:  Urologe A       Date:  2016-02       Impact factor: 0.639

3.  [Documentation quality of histopathology reports of prostate needle biopsies: a snapshot].

Authors:  S Biesterfeld
Journal:  Urologe A       Date:  2014-11       Impact factor: 0.639

4.  [Clinical insignificance of prostate cancer: are there morphological findings?].

Authors:  B Helpap; L Egevad
Journal:  Urologe A       Date:  2009-02       Impact factor: 0.639

Review 5.  The presence of secondary circulating prostate tumour cells determines the risk of biochemical relapse for patients with low- and intermediate-risk prostate cancer who are treated only with external radiotherapy.

Authors:  Nigel P Murray; Socrates Aedo; Cynthia Fuentealba; Eduardo Reyes; Simone Minzer; Aníbal Salazar
Journal:  Ecancermedicalscience       Date:  2018-06-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.